Cbl-b-IN-10
Cbl-b-IN-10 (Compound 463) is a casitas B-lineage lymphoma-b (Cbl-b) and c-Cbl inhibitor with IC50s of 6.0 nM and 3.5 nM, respectively[1].
Product Specifications
CAS Number
[2815225-12-6]
UNSPSC
12352005
Target
E1/E2/E3 Enzyme
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cbl-b-in-10.html
Solubility
10 mM in DMSO
Smiles
O=C1C2=CC(CNC3(CCC3)C)=CC(C(F)(F)F)=C2CN1C4=CC(NCC)=CC(C5(CCC5)CC6=NN=CN6C)=C4
Molecular Formula
C31H37F3N6O
Molecular Weight
566.66
References & Citations
[1]Jun Liang, et al. Lactams as cbl-b inhibitors. Patent WO2022169997A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
282291-01 2 mg
Methyl 1,4-dihydro-2,6-dimethyl-4- (2'-trifluoromethyl) phenyl-pyridine-5-carboxylate-3-phenylmethyl carboxamide
Ask
View Details 282291-02 5 mg
Methyl 1,4-dihydro-2,6-dimethyl-4- (2'-trifluoromethyl) phenyl-pyridine-5-carboxylate-3-phenylmethyl carboxamide
Ask
View Details 282291-03 10 mg
Methyl 1,4-dihydro-2,6-dimethyl-4- (2'-trifluoromethyl) phenyl-pyridine-5-carboxylate-3-phenylmethyl carboxamide
Ask
View Details 282291-04 25 mg
Methyl 1,4-dihydro-2,6-dimethyl-4- (2'-trifluoromethyl) phenyl-pyridine-5-carboxylate-3-phenylmethyl carboxamide
Ask
View Details